Renal Protection for Coronary Angiography in Advanced Renal Failure Patients by Prophylactic Hemodialysis. A Randomized Controlled Trial

Journal of the American College of Cardiology

Volumn 50, Issue 11, 2007, Pages 1015-1020

  Lee, Po Tsang ^a,b,c   Chou, Kang Ju ^a,b   Liu, Chun Peng ^a   Mar, Guang Yuan ^a   Chen, Chien Liang ^a,b   Hsu, Chih Yang ^a   Fang, Hua Chang ^a,b   Chung, Hsiao Min ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FUROSEMIDE; SODIUM CHLORIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL PROTECTION; RISK FACTOR;

AGED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; FEMALE; HUMANS; IOHEXOL; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 34548364097     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.05.033     Document Type: Article

References (28)

1. Murphy S.W., Barrett B.J., and Parfrey P.S. Contrast nephropathy. J Am Soc Nephrol 11 (2000) 177-182
2. McCullough P.A., Wolyn R., Rocher L.L., et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
3. Shusterman N., Strom B.L., Murray T.G., et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med 83 (1987) 65-71
4. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
5. Weinrauch L.A., Healy R.W., Leland Jr. O.S., et al. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 86 (1977) 56-59
6. Shafi T., Shyan-Yik C., Porush J.G., and Shapiro W.B. Infusion intravenous pyelography and renal function: effects of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med 138 (1978) 1218-1221
7. Porter G.A. Contrast associated nephropathy: presentation, pathophysiology and management. In: DeBroe M.E. (Ed). Clinical Nephrotoxins (1998), Kluwer Academic, Dordrecht, the Netherlands 317-331
8. Solomon R., Werner C., Mann D., et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331 (1994) 1416-1420
9. Schwab S.J., Hlatky M.A., Pieper K.S., et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 320 (1989) 149-153
10. Stein E.P., Moore R.D., Powe N.R., et al. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med 326 (1992) 425-430
11. Aspelin P., Aubry P., Frausson S.G., et al. Nephrotoxic effects in high-risk patients undergoing angioplasty. N Engl J Med 348 (2003) 491-499
12. Cigarroa R.G., Lange R.A., Williams R.H., and Hillis L.D. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86 (1989) 649-652
13. Solomon R., Deray G., and Consensus Panel for C.I.N. How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations. Kidney Int Suppl 100 (2006) S51-S53
14. Birck R., Krzossok S., Markowetz F., et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362 (2003) 598-603
15. Marenzi G., Assanelli E., Marana I., et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 354 (2006) 2773-2782
16. Lorusso V., Taroni P., Alvino S., and Spinazzi A. Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end stage renal disease requiring haemodialysis. Invest Radiol 36 (2001) 309-316
17. Jungers P., Nguyen K.T., Massy Z.A., et al. Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients: a multicentric study in the Ile de France district. Nephrol Dial Transplant 14 (1999) 898-902
18. McCullough P.A., and Sandberg K.R. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 4 (2003) S3-S9
19. Gruberg L., Mehran R., Dangas G., et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 52 (2001) 409-416
20. Vogt B., Ferrari P., Schonholzer C., et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111 (2001) 692-698
21. Tumlin J., Stacul F., Adam A., et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 98 Suppl 1 (2006) 14-20
22. Corradi A., Menta R., Cambi V., et al. Pharmacokinetics of iopamidol in adults with renal failure. Arzneimittelforschung 40 (1990) 830-832
23. Waaler A., Svaland M., Fauchald P., et al. Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure. Nephron 56 (1990) 81-85
24. Ueda J., Furukawa T., Takahashi S., et al. Elimination of ioversol by hemodialysis. Acta Radiol 37 (1996) 826-829
25. Matzkies F.K., Reinecke H., Tombach B., et al. Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function. Am J Nephrol 20 (2000) 300-304
26. Frank H., Werner D., Lorusso V., et al. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol 60 (2003) 176-182
27. Marenzi G., Marana I., Lauri G., et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 349 (2003) 1333-1340
28. Marenzi G., Lauri G., and Campodonico J. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 119 (2006) 155-162